Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

…, H Ito, H Iwata, K Tajima, P Guénel, T Truong, C Mulot… - Nature …, 2015 - nature.com
Genome-wide association studies (GWAS) and large-scale replication studies have identified
common variants in 79 loci associated with breast cancer, explaining ∼14% of the familial …

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

…, JL Schultze, O Kepp, G Stoll, C Lefebvre, C Mulot… - Science, 2015 - science.org
Antitumor immunity driven by intratumoral dendritic cells contributes to the efficacy of
anthracycline-based chemotherapy in cancer. We identified a loss-of-function allele of the gene …

Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study)

…, N Sarafan-Vasseur, P Michel, G Perkins, C Mulot… - Clinical Cancer …, 2017 - AACR
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are
essential for optimization of treatment strategies. We evaluated the applicability of early changes …

[PDF][PDF] Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05

…, O Bouché, D Le Corre, I Miran, C Mulot… - Journal of Clinical …, 2010 - researchgate.net
Purpose The aim was to investigate whether germline polymorphisms within candidate
genes known or suspected to be involved in fluorouracil (FU), oxaliplatin, and irinotecan …

[HTML][HTML] Breast cancer risk, nightwork, and circadian clock gene polymorphisms

…, P Laurent-Puig, C Mulot… - Endocrine-related …, 2014 - erc.bioscientifica.com
Night shift work has been associated with an increased risk of breast cancer pointing to a
role of circadian disruption. We investigated the role of circadian clock gene polymorphisms …

Association between Parkinson's disease and the HLA‐DRB1 locus

…, R Krishnamoorthy, C Tzourio, C Mulot… - Movement …, 2012 - Wiley Online Library
Two genome‐wide association studies (GWASs) recently highlighted the HLA‐DRA and
HLA‐DRB5 genes as associated with Parkinson disease (PD). However, because HLA‐DRA …

A study of hypermethylated circulating tumor DNA as a universal colorectal cancer biomarker

…, A Didelot, D Le Corre, S Peyvandi, C Mulot… - Clinical …, 2016 - academic.oup.com
BACKGROUND Circulating tumor DNA (ctDNA) has emerged as a good candidate for tracking
tumor dynamics in different cancer types, potentially avoiding repeated tumor biopsies. …

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

…, T Truong, M Sanchez, C Mulot… - Human molecular …, 2014 - academic.oup.com
Candidate variant association studies have been largely unsuccessful in identifying common
breast cancer susceptibility variants, although most studies have been underpowered to …

Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France …

…, M Mabro, J Egreteau, O Bouche, C Mulot… - Clinical Cancer …, 2021 - AACR
Purpose: Circulating tumor DNA (ctDNA) has been suggested as a major prognostic factor in
resected stage-III colon cancer. We analyzed ctDNA of patients randomized in the phase III …

Collection of human genomic DNA from buccal cells for genetics studies: comparison between cytobrush, mouthwash, and treated card

C Mulot, I Stücker, J Clavel, P Beaune… - BioMed Research …, 2005 - hindawi.com
Alternative sources such as buccal cells have already been tested for genetic studies and
epidemiological investigations. Thirty-seven volunteers participated in this study to compare …